SCHEMBL6415907

SCHEMBL6415907

NN=C(c1ccc(-c2cccc(C(N)=O)c2)o1)c1nc2nonc2nc1Nc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.41
ATR Q13535 1/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TGFBR1 P36897 1/20 0.36
FAAH O00519 1/20 0.35
KDR P35968 1/20 0.35
SYK P43405 2/20 0.35
PIK3CD O00329 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
SLC9A1 P19634 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6413428 0.94 BIRC5 (0.47) BIRC5ATRALDH1A1KDM4EPOLB
SCHEMBL6419710 0.92 MAPT (0.40) BIRC5ALDH1A1KDM4EPOLBMAPT
SCHEMBL6416017 0.89 KDR (0.38) BIRC5ALDH1A1KDM4EPOLBMAPT
SCHEMBL6432662 0.88 LDHA (0.40) BIRC5ALDH1A1KDM4EPOLBMAPT
SCHEMBL6434895 0.87 BIRC5 (0.45) BIRC5ALDH1A1KDM4EPOLBMAPT
SCHEMBL6415096 0.87 AURKA (0.38) BIRC5ALDH1A1POLBMAPTSYK
SCHEMBL6419244 0.86 BIRC5 (0.48) BIRC5ALDH1A1KDM4EPOLBMAPT
SCHEMBL6431830 0.86 BIRC5 (0.44) BIRC5ALDH1A1KDM4EPOLBMAPT
SCHEMBL6419747 0.84 BIRC5 (0.43) BIRC5ALDH1A1KDM4EPOLBMAPT
SCHEMBL6435669 0.82 MAPT (0.44) ALDH1A1KDM4EPOLBMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds 4SC AG (DE) 2005-06-30 US disclosed
WO-2005044270-A1 OXADIAZOLOPYRAZINE DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS 4SC AG (DE) 2005-05-19 WO disclosed
EP-1529531-A1 Oxadiazolopyrazine derivatives as pharmaceutically active compounds 4SC AG (DE) 2005-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds NR5A2, NR1H2, NR2C2 BIRC5 2525/4885ATR 2681/4885ALDH1A1 1119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.